The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

History | Epidemiology | Neurodevelopment and Etiology | Clinical Presentation | Differential Diagnosis: Other Psychotic Syndromes | Psychosocial Factors | Treatment | References

Excerpt

Schizophrenia, a neurodevelopmental disorder that most often manifests in late adolescence or early adulthood, causes significant disturbances in perception, emotion, cognitive function, and social relatedness. Early-onset schizophrenia (EOS) is a less common form of the illness, defined as onset before age 18 years. Childhood-onset schizophrenia (COS) refers to the rare occurrences of onset before age 13 years. Both COS and EOS are considered to be continuous with adult-onset schizophrenia (AOS) because all three have related clinical features and neurobiological abnormalities, but youth incidence is further affected by unique developmental and social challenges. In this chapter, we describe schizophrenia in children and adolescents, including its history, epidemiology, etiology, genetic contributions, and clinical presentation. We place special emphasis on EOS and the neurodevelopmental effect of illness across the life span. Current research highlighting effective psychosocial and pharmacological interventions is then reviewed, including clinical recommendations to help guide effective and comprehensive care for youth with schizophrenia and related disorders.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).